Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Total Current Liabilities (2021 - 2025)

Historic Total Current Liabilities for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $91.3 million.

  • Krystal Biotech's Total Current Liabilities rose 194.47% to $91.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.3 million, marking a year-over-year increase of 194.47%. This contributed to the annual value of $102.0 million for FY2024, which is 20819.79% up from last year.
  • Krystal Biotech's Total Current Liabilities amounted to $91.3 million in Q3 2025, which was up 194.47% from $86.9 million recorded in Q2 2025.
  • Krystal Biotech's 5-year Total Current Liabilities high stood at $102.0 million for Q4 2024, and its period low was $9.1 million during Q1 2021.
  • Over the past 5 years, Krystal Biotech's median Total Current Liabilities value was $35.1 million (recorded in 2023), while the average stood at $48.9 million.
  • Per our database at Business Quant, Krystal Biotech's Total Current Liabilities skyrocketed by 56094.71% in 2022 and then tumbled by 4196.27% in 2023.
  • Quarter analysis of 5 years shows Krystal Biotech's Total Current Liabilities stood at $25.7 million in 2021, then rose by 12.09% to $28.8 million in 2022, then rose by 14.72% to $33.1 million in 2023, then skyrocketed by 208.2% to $102.0 million in 2024, then dropped by 10.52% to $91.3 million in 2025.
  • Its Total Current Liabilities stands at $91.3 million for Q3 2025, versus $86.9 million for Q2 2025 and $79.5 million for Q1 2025.